As the healthcare industry looks to master AI everywhere, GenAI is emerging as a transformative force in healthcare and is set to impact workforce efficiency and hyper-personalisation in the care processes. Leaders in the healthcare sector are exploring the use cases and the adoption model within their establishments, realising the immense potential GenAI has in the future of healthcare.
“The Asia/Pacific healthcare sector is at a seminal moment, defined by a patient-centric care model combined with an ‘AI Everywhere’ approach says Manoj Vallikkat, senior research manager for Healthcare Insights at IDC Asia/Pacific.
“With the advent of GenAI and the need for consumerisation of care, the next five years are set to be the defining period for the healthcare sector, and we are currently at the starting point of this exciting journey.”Manoj Vallikkat
AI-driven predictions for the healthcare sector
GenAI PX: By the end of 2027, driven by the demand to scale hyper-personalised patient experiences, improve collaboration, and foster equity, 60% of Asia/Pacific healthcare organisations will double GenAI investments.
AI Diagnostics: Driven by the need for improved diagnostic accuracy, speed, and workflow efficiency, care providers in Asia/Pacific will see a 60% increase in AI solution adoption by 2026.
AI Care Anywhere: By 2027, 50% of the healthcare industry in Asia/Pacific will leverage GenAI to address data and workflow fragmentation across care settings to improve diagnosis and patient safety to scale care anywhere.
Other healthcare predictions
Special attention has been given towards optimising technology investments, with a particular emphasis on enhancing operational efficiency and elevating patient outcomes.
Industry Clouds: Driven by the perceived value of purpose-built functionalities for healthcare, 40% of healthcare organisations in Asia/Pacific will adopt industry clouds by 2025.
Payvider Financing: By 2026, 45% of Asia/Pacific private health insurance companies and 75% of U.S. health systems will be "payviders" to improve risk management and address the rising cost of care.
H@H: By 2026, a doubling of hospital-at-home patients will propel a 55% growth in investments in tech-enabled integrated care initiatives to address patient safety, workforce, and care access concerns in Asia/Pacific.
Techquity: By 2028, 60% of the healthcare industry in Asia/Pacific will prioritise tech partnerships that champion “techquity,” reducing the digital divide and recognising social determinants of health as vital influencers.
Integrated Platforms: Personalised health data platforms will support 50% of covered patients in advanced economies by 2028 while building more accurate patient journey simulations for providers and life science companies in Asia/Pacific.
Future of Hospitals: By 2029, hospital investments in sustainability and modernisation will increase by 50%, driven by the need to reduce costs, improve quality of care, and enhance organisational resiliency in Asia/Pacific.
“Equitable healthcare has always been a big headache for the healthcare sector, but the evolution of technology, such as AI, will provide viable means to reduce the gaps in digital healthcare,” says Louise Francis, head of public sector research with IDC Asia/Pacific.
She opined that the emergence of the concept of ‘techquity’ highlights how technology will provide the bridge to enabling equitable access to healthcare services over the next five years.
“Healthcare providers in the region tend to prioritise investments in data management, AI, and automation, targeting decentralised care and patient outcome, supported by enhanced clinician efficiency. In the healthcare sector, the unique risks associated with AI are significant, which necessitates a greater focus on explainability and data security,” Manoj concluded.